ANDA 77200, held by Alcon Pharmaceuticals. Ketotifen Fumarate.
As of Nov 21, 2026, ANDA 77200 (Zaditor), held by Alcon Pharmaceuticals, was first approved by FDA on Sep 2, 2008, with 1 approved supplement and 0 published complete response letters.
Use Temporarily relieves itchy eyes due to pollen, ragweed, grass, animal hair and dander.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 2, 2008 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| ZaditorEQ 0.025% BASE · solution/drops;ophthalmic | Ketotifen Fumarate | OTC |
| Sep 16, 2015 | Supplement 2Labeling · Standard review | Approved | None posted |
| Sep 2, 2008 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters